DK1404304T3 - Tablet omfattende cetirizin og pseudoephedrin - Google Patents
Tablet omfattende cetirizin og pseudoephedrinInfo
- Publication number
- DK1404304T3 DK1404304T3 DK02743173T DK02743173T DK1404304T3 DK 1404304 T3 DK1404304 T3 DK 1404304T3 DK 02743173 T DK02743173 T DK 02743173T DK 02743173 T DK02743173 T DK 02743173T DK 1404304 T3 DK1404304 T3 DK 1404304T3
- Authority
- DK
- Denmark
- Prior art keywords
- tablet
- cetirizine
- pseudoephedrine
- combinations
- treatment
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
- A61K31/137—Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine or methadone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
- A61K9/2086—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat
- A61K9/209—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat containing drug in at least two layers or in the core and in at least one outer layer
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/02—Nasal agents, e.g. decongestants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
Landscapes
- Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Epidemiology (AREA)
- Pulmonology (AREA)
- Ophthalmology & Optometry (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Immunology (AREA)
- Emergency Medicine (AREA)
- Otolaryngology (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Plant Substances (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US30125001P | 2001-06-28 | 2001-06-28 | |
| EP01115807 | 2001-06-28 | ||
| PCT/EP2002/006342 WO2003002098A1 (en) | 2001-06-28 | 2002-06-10 | Tablet comprising cetirizine and pseudoephedrine |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DK1404304T3 true DK1404304T3 (da) | 2009-07-13 |
Family
ID=56290291
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK02743173T DK1404304T3 (da) | 2001-06-28 | 2002-06-10 | Tablet omfattende cetirizin og pseudoephedrin |
Country Status (22)
| Country | Link |
|---|---|
| EP (1) | EP1404304B1 (et) |
| JP (1) | JP4041460B2 (et) |
| KR (1) | KR100926410B1 (et) |
| CN (1) | CN100490809C (et) |
| AT (1) | ATE432068T1 (et) |
| AU (1) | AU2002345024B2 (et) |
| BR (1) | BR0210650A (et) |
| CA (1) | CA2451519C (et) |
| CZ (1) | CZ20033454A3 (et) |
| DK (1) | DK1404304T3 (et) |
| EE (1) | EE05357B1 (et) |
| ES (1) | ES2324769T3 (et) |
| HU (1) | HU229803B1 (et) |
| MX (1) | MXPA03010430A (et) |
| NZ (1) | NZ530289A (et) |
| PL (1) | PL206069B1 (et) |
| PT (1) | PT1404304E (et) |
| RO (1) | RO122476B1 (et) |
| RU (1) | RU2286784C2 (et) |
| SI (1) | SI1404304T1 (et) |
| SK (1) | SK287645B6 (et) |
| WO (1) | WO2003002098A1 (et) |
Families Citing this family (17)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IL159287A0 (en) * | 2001-06-28 | 2004-06-01 | Ucb Farchim Sa | Tablet comprising cetirizine and pseudoephedrine |
| KR100698400B1 (ko) | 2004-04-14 | 2007-03-23 | 이은주 | 탈모증 및 전립선비대증 치료를 위한 약제학적 조성물 |
| US20100172984A1 (en) * | 2006-06-06 | 2010-07-08 | Bijay Kumar Padhi | tablet dosage form comprising cetirizine and pseudoephedrine |
| ES2529147T3 (es) * | 2006-12-26 | 2015-02-17 | Pharmacyclics, Inc. | Método para usar los inhibidores de la histona deacetilasa y monitorear biomarcadores en la terapia de combinación |
| US8439033B2 (en) | 2007-10-09 | 2013-05-14 | Microdose Therapeutx, Inc. | Inhalation device |
| CA2784041C (en) | 2010-01-05 | 2017-11-07 | Microdose Therapeutx, Inc. | Inhalation device and method |
| KR101193495B1 (ko) | 2010-02-01 | 2012-10-23 | 한미사이언스 주식회사 | 슈도에페드린 및 레보세티리진을 포함하는 경구용 복합 조성물 |
| EP2799071B1 (en) | 2010-06-16 | 2018-10-17 | Inflammatory Response Research, Inc. | Levocetirizine and montelukast for the treatment of influenza and common cold |
| CN102302497A (zh) * | 2011-05-18 | 2012-01-04 | 天圣制药集团股份有限公司 | 一种治疗过敏性鼻炎的制剂及其制备方法 |
| KR20130009553A (ko) | 2011-07-15 | 2013-01-23 | 한미약품 주식회사 | 몬테루카스트 또는 이의 약학적으로 허용가능한 염 및 레보세티리진 또는 이의 약학적으로 허용가능한 염을 함유하는 캡슐 제제 |
| CN103917231B (zh) | 2011-09-13 | 2016-09-28 | 药品循环有限责任公司 | 组蛋白脱乙酰酶抑制剂与苯达莫司汀的联合制剂及其用途 |
| KR101372324B1 (ko) * | 2012-02-09 | 2014-03-13 | 동국대학교 경주캠퍼스 산학협력단 | 알러지성 비염 치료를 위한 한방 치료제 및 슈도에페드린을 함유한 복합서방형의 약제학적 조성물 |
| ES2660494T3 (es) | 2013-03-13 | 2018-03-22 | 14779507 | Uso de levocetirizina y montelukast en el tratamiento de una lesión traumática |
| JP2016512262A (ja) | 2013-03-13 | 2016-04-25 | インフラマトリー・レスポンス・リサーチ・インコーポレイテッド | 血管炎の処置におけるレボセチリジン及びモンテルカストの使用 |
| EP3300734B1 (en) | 2013-03-13 | 2019-08-14 | Inflammatory Response Research, Inc. | Use of levocetirizine and montelukast in the treatment of autoimmune disorders |
| JP2017526728A (ja) | 2014-09-15 | 2017-09-14 | インフラマトリー・レスポンス・リサーチ・インコーポレイテッド | 炎症介在性状態の治療におけるレボセチリジン及びモンテルカスト |
| WO2016140630A1 (en) | 2015-03-05 | 2016-09-09 | PHARMACTIVE ILAÇ SANAYI VE TlCARET A. Ş. | An effervescent composition comprising levocetirizine and pseudoephedrine |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0811374A1 (en) * | 1996-05-29 | 1997-12-10 | Pfizer Inc. | Combination dosage form comprising cetirizine and pseudoephedrine |
| BE1011045A3 (fr) * | 1997-03-14 | 1999-04-06 | Ucb Sa | Compositions pharmaceutiques pour la liberation controlee de substances actives. |
| US6267986B1 (en) * | 1999-09-24 | 2001-07-31 | Ranbaxy Laboratories Limited | Process for the preparation of a controlled drug delivery system containing pseudoephedrine and a long acting antihistamine |
-
2002
- 2002-06-10 HU HU0400386A patent/HU229803B1/hu unknown
- 2002-06-10 RO ROA200301062A patent/RO122476B1/ro unknown
- 2002-06-10 PL PL366800A patent/PL206069B1/pl unknown
- 2002-06-10 AT AT02743173T patent/ATE432068T1/de active
- 2002-06-10 EE EEP200400005A patent/EE05357B1/et unknown
- 2002-06-10 ES ES02743173T patent/ES2324769T3/es not_active Expired - Lifetime
- 2002-06-10 SI SI200230844T patent/SI1404304T1/sl unknown
- 2002-06-10 SK SK1550-2003A patent/SK287645B6/sk not_active IP Right Cessation
- 2002-06-10 DK DK02743173T patent/DK1404304T3/da active
- 2002-06-10 JP JP2003508337A patent/JP4041460B2/ja not_active Expired - Fee Related
- 2002-06-10 CN CNB02812975XA patent/CN100490809C/zh not_active Expired - Lifetime
- 2002-06-10 RU RU2004101231/15A patent/RU2286784C2/ru active
- 2002-06-10 WO PCT/EP2002/006342 patent/WO2003002098A1/en active Application Filing
- 2002-06-10 AU AU2002345024A patent/AU2002345024B2/en not_active Ceased
- 2002-06-10 MX MXPA03010430A patent/MXPA03010430A/es active IP Right Grant
- 2002-06-10 NZ NZ530289A patent/NZ530289A/en unknown
- 2002-06-10 KR KR1020037017054A patent/KR100926410B1/ko active IP Right Grant
- 2002-06-10 CA CA002451519A patent/CA2451519C/en not_active Expired - Lifetime
- 2002-06-10 EP EP02743173A patent/EP1404304B1/en not_active Expired - Lifetime
- 2002-06-10 BR BR0210650-7A patent/BR0210650A/pt not_active Application Discontinuation
- 2002-06-10 PT PT02743173T patent/PT1404304E/pt unknown
- 2002-06-10 CZ CZ20033454A patent/CZ20033454A3/cs unknown
Also Published As
| Publication number | Publication date |
|---|---|
| NZ530289A (en) | 2004-11-26 |
| SI1404304T1 (sl) | 2009-10-31 |
| PT1404304E (pt) | 2009-06-26 |
| RO122476B1 (ro) | 2009-07-30 |
| CZ20033454A3 (cs) | 2004-08-18 |
| SK287645B6 (sk) | 2011-05-06 |
| RU2286784C2 (ru) | 2006-11-10 |
| EP1404304A1 (en) | 2004-04-07 |
| ATE432068T1 (de) | 2009-06-15 |
| RU2004101231A (ru) | 2005-04-20 |
| JP2004536829A (ja) | 2004-12-09 |
| SK15502003A3 (sk) | 2004-05-04 |
| ES2324769T3 (es) | 2009-08-14 |
| CN100490809C (zh) | 2009-05-27 |
| EE05357B1 (et) | 2010-12-15 |
| HUP0400386A3 (en) | 2006-02-28 |
| BR0210650A (pt) | 2004-10-05 |
| WO2003002098A1 (en) | 2003-01-09 |
| PL366800A1 (en) | 2005-02-07 |
| KR20040007756A (ko) | 2004-01-24 |
| AU2002345024B2 (en) | 2006-09-07 |
| EP1404304B1 (en) | 2009-05-27 |
| HUP0400386A2 (hu) | 2004-08-30 |
| JP4041460B2 (ja) | 2008-01-30 |
| CN1520285A (zh) | 2004-08-11 |
| CA2451519A1 (en) | 2003-01-09 |
| HU229803B1 (en) | 2014-07-28 |
| PL206069B1 (pl) | 2010-06-30 |
| KR100926410B1 (ko) | 2009-11-12 |
| EE200400005A (et) | 2004-02-16 |
| MXPA03010430A (es) | 2004-12-06 |
| CA2451519C (en) | 2007-11-06 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DK1404304T3 (da) | Tablet omfattende cetirizin og pseudoephedrin | |
| ATE350375T1 (de) | 17beta-hydroxysteroid dehydrogenase type 3 inhibitoren zur behandlung von androgen- abhängigen erkrankungen | |
| ATE396202T1 (de) | Lang wirkendes glucagon-ähnliches peptid-2 für die behandlung von gastrointestinalen krankheiten und störungen | |
| ATE318590T1 (de) | Arzneimittelkombinationen (z.b. chlorpromazin und pentamidin) zur therapie von neoplastischen erkrankungen | |
| NO20044192L (no) | 17alfa-alkyl-17beta-oksy-ostratriener og farmasoytiske preparater | |
| CY1109238T1 (el) | Δισκιο περιεχον σετιριζινη και ψευδοεφεδρινη | |
| DK1663978T3 (da) | Fluorsubstitueret omega-carboxyaryl-diphenylurinstof til behandling og forebyggelse af sygdomme og lidelser | |
| DE60225385D1 (de) | Autentisches Document und dessen Herstellungsverfahren | |
| NO20052855D0 (no) | Fosfonoksykinazolinderivater og farmasoytisk anvendelse derav. | |
| DE60216122D1 (de) | Cysteinprotease-hemmer mit 2-cyano-4-amino-pyrimidinstruktur und cathepsin-k-hemmender wirkung zur behandlung von entzündungen und anderen erkrankungen | |
| NO20034056D0 (no) | Proliferative sykdommer | |
| DK1513873T3 (da) | Terapeutiske epitoper og anvendelser deraf | |
| PT1392292E (pt) | Piranoindazoles e sua utilizacao para o tratamento de glaucoma | |
| NO20055173D0 (no) | Farmasoytisk kombinasjonsblanding omfattende modafinil og et annet legemiddel | |
| NO20024528L (no) | Proteaseinhibitor, farmasoytisk sammensetning og anvendelse av forbindelsen | |
| DK1781277T3 (da) | Kombinationssammensætning, der omfatter Ibuprofen og Paracetamol | |
| NO20051983D0 (no) | 3-fenyl-substituert pyridoindolon, fremstilling derav og terapeutisk anvendelse derav. | |
| DK1546127T3 (da) | Nye pyrimidinamidderivater og anvendelse deraf | |
| IS7798A (is) | Efnasambönd, lyfjablöndur og aðferðir | |
| NO20033123D0 (no) | Terapeutisk hinnedannende sammensetning og behandlingsplan derav | |
| ATE282607T1 (de) | Tryptase-inhibitoren | |
| ATE389392T1 (de) | Paracetamol enthaltende tablette | |
| NO20040214L (no) | Kombinasjoner som innebefatter epotiloner og farmasoytiske anvendelser derav | |
| DK1849468T3 (da) | Farmaceutisk sammensætning omfattende roflumilast og levocetirizin | |
| DK1530462T3 (da) | 1-phenyl-2-dimethylaminomethylcyclohexanforbindelser til behandling af depressionssymtomer. smerte og inkontinens |